Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study

Innovative treatment modalities have not yet shown a clinical benefit in patients with septic shock. To reduce severe cytokinaemia, CytoSorb as an add-on to continuous renal replacement therapy (CRRT) showed p...

Source: Critical Care - September 18, 2019 Category: Intensive Care Authors: Willem Pieter Brouwer, Servet Duran, Martijn Kuijper and Can Ince Tags: Research Source Type: research